These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36701361)

  • 1. Will R&D make investors more tolerant? Analysis based on the performance forecast of Chinese listed companies.
    Chen Y; Wang Y; Zhao H; Xu W
    PLoS One; 2023; 18(1):e0280237. PubMed ID: 36701361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional investors and cost of capital: The moderating effect of ownership structure.
    Huo X; Lin H; Meng Y; Woods P
    PLoS One; 2021; 16(4):e0249963. PubMed ID: 33831116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do Institutional Investors Influence Corporate Governance under Legal Psychology.
    Qi S
    J Environ Public Health; 2022; 2022():5004309. PubMed ID: 35978593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the R&D Expenditure of Listed Companies Green? Evidence from China's A-Share Market.
    Li B; Li L; Pi T
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualified foreign institutional investors and corporate innovation: From the perspective of corporate governance.
    Wang X; Wang W; Shi XY
    Front Psychol; 2022; 13():1005409. PubMed ID: 36467163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indifferent to CSR performance? Market liberalization brings about changes.
    Zhou H; Xu L
    Heliyon; 2023 Nov; 9(11):e22172. PubMed ID: 38045161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive pharmaceutical background, R&D investment and corporate innovation performance.
    Zhang L; Li S; Wu M
    Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of enterprise financialization on green innovation: evidence from Chinese A-share non-financial listed enterprises.
    Li W; Chen L; He S
    Environ Sci Pollut Res Int; 2023 Apr; 30(19):56802-56817. PubMed ID: 36929262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can venture capital shareholding improve M&A performance? An empirical study based on Chinese GEM-listed companies.
    Chao K; Wang M; Hu Y; Wang S
    PLoS One; 2024; 19(8):e0308932. PubMed ID: 39146381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green investor behavior and corporate green innovation: Evidence from Chinese listed companies.
    Tang H; Tong M; Chen Y
    J Environ Manage; 2024 Aug; 366():121691. PubMed ID: 39008924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of insurance institutional investors on corporate value from selection and creation perspective.
    Rong X; Zhang T; Liu K
    PLoS One; 2022; 17(7):e0269520. PubMed ID: 35776721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corporate Social Responsibility Disclosure: Responding to Investors' Criticism on Social Media.
    Zhang Y; Yang F
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institutional investors' site visits and investment-cash flow sensitivity: Mitigating financing constraints or inhibiting agent conflicts?
    Liao J; Zhan Y; Yuan Y
    PLoS One; 2024; 19(3):e0300332. PubMed ID: 38547151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of accounting conservatism on enterprise innovation investment.
    Zou W; Othman A
    Heliyon; 2024 Aug; 10(16):e36106. PubMed ID: 39253180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research on the Effect of Executive Incentive Institutional Innovation on the Cost of Equity-Evidence From Chinese Listed Companies.
    Wang J; Deng J
    Front Psychol; 2021; 12():686955. PubMed ID: 34168600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does investors' site visits improve the capital market pricing efficiency?
    Li N; Yuan R; Khan MA; Yang X; Khaliq N; Zhang X
    Heliyon; 2023 Sep; 9(9):e19100. PubMed ID: 37662731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China.
    Yi Y; Xie B; Zhou L; Wei Y
    PLoS One; 2020; 15(2):e0227952. PubMed ID: 32032381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does venture capital Quan Zi affect stock mispricing: Evidence from Chinese listed companies.
    Chen P; Deng L
    PLoS One; 2023; 18(4):e0281255. PubMed ID: 37053247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can retail investors induce corporate green innovation? -Evidence from Baidu Search Index.
    Li M; Li N; Khan MA; Khaliq N; Rehman FU
    Heliyon; 2022 Jun; 8(6):e09663. PubMed ID: 35721685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which institutional investors can improve the level of corporate ESG information disclosure?
    Wang J; Ke Y; Zhang H; Cheng Y
    PLoS One; 2023; 18(11):e0290008. PubMed ID: 37976317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.